For nearly 25 years, GlaxoSmithKline’s (“GSK”) Zofran (ondansetron) has been used to alleviate nausea and vomiting in cancer patients enduring chemotherapy or radiation therapy—however the FDA has never approved the anti-nausea medicine for use in pregnant women. Unfortunately, GSK’s alleged “off label” marketing of the drug to expectant mothers may have cost one family...
Off-label uses of certain drugs can lead to serious harm. Our website discusses dangerous prescription drugs in more detail.
Alabama Family Claims Zofran (ondansetron) Caused Heart Defects
Joining over 50 existing cases, another lawsuit has been filed alleging anti-nausea drug Zofran (ondansetron) was responsible for causing birth defects. The complaint contends that GlaxoSmithKline (“GSK”) marketed Zofran (ondansetron) “off label,” even though it was only approved for use by the FDA for treatment of severe nausea and vomiting in cancer patients or...
